Zullo Investment Group’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-300
Closed -$14.4K 453
2022
Q4
$14.4K Hold
300
0.01% 437
2022
Q3
$11K Hold
300
0.01% 470
2022
Q2
$8K Hold
300
0.01% 534
2022
Q1
$16K Hold
300
0.01% 461
2021
Q4
$18K Buy
+300
New +$18K 0.01% 442